ORIGINAL RESEARCH article
Front. Med.
Sec. Nephrology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1627412
Shenyuan Granules improve cellular senescence through Klotho-mediated p16/p21 signaling pathway in diabetic kidney disease
Provisionally accepted
- Hubei University of Chinese Medicine, Wuhan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Context: Shenyuan Granules (SYG), a traditional Chinese medicine preparation, are clinically used for treating chronic kidney diseases. However, the role of Klotho in modulating cellular senescence via the p16/p21 pathway and its involvement in the therapeutic effects of SYG in diabetic kidney disease (DKD) remains unclear.Objective: This study investigated the regulatory effects of SYG on the Klotho gene and their mechanisms in alleviating cellular senescence in DKD.Utilizing an adenine-induced DKD model in db/db mice and AGEstimulated HK-2 cells, this research assessed renal tissue for cellular senescence and pathological changes. Techniques such as SA-β-gal, HE, and PAS staining were employed to observe these changes. The study also measured the expression levels of senescence-associated and anti-aging markers including Klotho, cyclin-dependent kinase inhibitor 2A (p16), cyclin-dependent kinase inhibitor p21 (p21), plasminogen activator inhibitor-1. Quantification of senescent cells was performed using SA-β-gal staining, while mRNA and protein expressions were analyzed using immunofluorescence, real-time PCR, and Western blotting.Results: SYG treatment significantly improved renal function in db/db mice and alleviated histopathological lesions. SA-β-Gal staining demonstrated a marked decrease in senescent cell burden, while immunohistochemistry and Western blotting revealed downregulation of p16, p21, and PAI-1 and upregulation of Klotho expression (P<0.05). In vitro, Klotho overexpression in AGE-stimulated HK-2 cells significantly suppressed senescence-associated markers and restored Lamin B1 expression. Similarly, treatment with SYG-containing serum effectively downregulated p16, p21, and 3 PAI-1 while upregulating Klotho expression. These findings suggest that SYG attenuate renal cellular senescence by modulating the Klotho-mediated p16/p21 signaling pathway.Discussion: This study highlights the potential of SYG to alleviate cellular senescence in DKD by targeting the Klotho-mediated p16/p21 pathway. These findings provide a foundation for developing senescence-focused therapies in chronic kidney disease management.
Keywords: Traditional Chinese Medicine, Shenyuan granules, cellular senescence, Klotho, p16, p21
Received: 12 May 2025; Accepted: 14 Jul 2025.
Copyright: © 2025 Guo, Zhang, Sun, Li and WANG. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: LAN WANG, Hubei University of Chinese Medicine, Wuhan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.